Sleep drug dosage study warns of risks for kidney patients
NCT ID NCT07381101
Summary
This study looked at whether starting a higher dose of the medication trazodone (used for sleep and depression) is riskier than a lower dose for older adults with reduced kidney function. Researchers analyzed health records of over 31,000 people in Ontario to see if the higher dose was linked to more hospital visits, emergency room trips, or death within 30 days. The goal is to provide clearer safety information to help doctors prescribe more safely for this vulnerable group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLDER ADULTS (65 YEARS AND OLDER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
London Health Sciences Centre Research Institute
London, Ontario, Canada
Conditions
Explore the condition pages connected to this study.